Brevan Howard Capital Management LP Sangamo Therapeutics, Inc Transaction History
Brevan Howard Capital Management LP
- $9.23 Billion
- Q1 2025
A detailed history of Brevan Howard Capital Management LP transactions in Sangamo Therapeutics, Inc stock. As of the latest transaction made, Brevan Howard Capital Management LP holds 66,018 shares of SGMO stock, worth $35,649. This represents 0.0% of its overall portfolio holdings.
Number of Shares
66,018Holding current value
$35,649% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding SGMO
# of Institutions
137Shares Held
51.2MCall Options Held
2.17MPut Options Held
1.82M-
Vanguard Group Inc Valley Forge, PA9.37MShares$5.06 Million0.0% of portfolio
-
Wasatch Advisors Inc Salt Lake City, UT6.87MShares$3.71 Million0.03% of portfolio
-
Black Rock Inc. New York, NY4.7MShares$2.54 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny3.17MShares$1.71 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA2.28MShares$1.23 Million0.0% of portfolio
About SANGAMO THERAPEUTICS, INC
- Ticker SGMO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 156,552,992
- Market Cap $84.5M
- Description
- Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a technology platform for making zinc finger nucle...